Neonatal Morbidity After Elective Repeat Cesarean Section and Trial of Labor

PEDIATRICS ◽  
1997 ◽  
Vol 100 (3) ◽  
pp. 348-353 ◽  
Author(s):  
B. Hook ◽  
R. Kiwi ◽  
S. B. Amini ◽  
A. Fanaroff ◽  
M. Hack
Keyword(s):  
Cesarean Section ◽  
Neonatal Morbidity ◽  
Trial Of Labor ◽  
Repeat Cesarean Section ◽  
Elective Repeat Cesarean

Neonatal Outcome after Trial of Labor Compared with Elective Repeat Cesarean Section

Birth ◽  
2003 ◽  
Vol 30 (2) ◽  
pp. 83-88 ◽  
Author(s):  
Rita E. Fisler ◽  
Amy Cohen ◽  
Steven A. Ringer ◽  
Ellice Lieberman
Keyword(s):  
Cesarean Section ◽  
Neonatal Outcome ◽  
Trial Of Labor ◽  
Repeat Cesarean Section ◽  
Elective Repeat Cesarean

scholarly journals 833: Elective repeat cesarean section (ERCD) at term for all: is fear of trial of labor after cesarean (TOLAC) justified?

2016 ◽  
Vol 214 (1) ◽  
pp. S433-S434
Author(s):  
Yael Cohen ◽  
Tamar Stevei ◽  
Rivka Farkash ◽  
Arnon Samueloff ◽  
Sorina Grisaru-Granovsky
Keyword(s):  
Cesarean Section ◽  
Trial Of Labor ◽  
Repeat Cesarean Section ◽  
Elective Repeat Cesarean

scholarly journals Trail of labor versus elective repeat cesarean section: a comparison of morbidity and mortality at tertiary care teaching hospitals in India

2018 ◽  
Vol 7 (11) ◽  
pp. 4476
Author(s):  
Balwan Singh Dhillon ◽  
Nomita Chandhiok ◽  
M. Vishnu Vardhana Rao
Keyword(s):  
Cesarean Section ◽  
Maternal Morbidity ◽  
Management Practices ◽  
Tertiary Care ◽  
Teaching Hospitals ◽  
Previous Cesarean Section ◽  
Trial Of Labor ◽  
Repeat Cesarean Section ◽  
Elective Repeat Cesarean ◽  
Previous Cesarean

Background: As cesarean birth rates continue to rise, more women are faced with the choice of planning a vaginal delivery or a repeat cesarean section after a previous cesarean section. The objective of this prospective study was to study the morbidities and mortality of women attempting a trial of labor after cesarean (TOLAC) versus elective repeat cesarean section (El-RCS).Methods: Prospective data was recorded on management practices, associated complications and morbidity & mortality for a period of 8 months on 15664 consecutive cases of previous cesarean section reporting at 30 medical colleges/ teaching hospitals for delivery.Results: A trial of labor was planned in 25.8% (4035) women and 34.5% (5399) women underwent elective repeat cesarean section and rest had emergency repeat cesarean section. Overall maternal morbidity due to any cause was 20.7% among El-RCS as compared to 14.2% in TOLAC which was statistically significant (OR: 1.57, CI: 1.41-1.76, P=0.00). Blood loss of more than 1000ml was around 8.0% among TOLAC where as in El-RCS it was 8.8% (OR: 0.89, CI: 0.77-1.94, p=0.14 not statistically significant). Blood transfusion was given in 3.7% in TOLAC where as in El-RCS it was given in 6.5% (OR: 0.56, CI: 0.45-0.68, p=0.00 highly significant).  Complication like dehiscence of scar was similar in both groups. Post-operative complication were seen in 2.8% cases in TOLAC where as in El-RCS it was 5.8% (OR: 0.47, CI: 0.38-0.59, p=0.00 highly significant). Uterine rupture was 0.3% in TOLAC where as in El-RCS it was 0.7% (OR: 0.43, CI: 0.21-0.87, p=0.009 statistically significant). Maternal mortality was reported in 0.2% cases of TOLAC as compared to 0.1% cases in El-RCS (p=0.17) which was not statistically significant.Conclusions: Maternal morbidity was found to be more in elective repeat cesarean section than trial of labor after cesarean section.

STUDIES OF CARBOHYDRATE METABOLISM IN THE NEWBORN INFANT

PEDIATRICS ◽  
1962 ◽  
Vol 30 (5) ◽  
pp. 769-775
Author(s):  
William Oh ◽  
Gloria S. Baens ◽  
Claude J. Migeon ◽  
Susan H. Wybregt ◽  
Marvin Cornblath
Keyword(s):  
Cesarean Section ◽  
Carbohydrate Metabolism ◽  
Newborn Infant ◽  
Repeat Cesarean Section ◽  
Elective Repeat Cesarean

Cortisol administered to the mother prior to elective repeat cesarean section resulted in an increased level of this hormone in both the mother and the infant's blood at the time of delivery. Cortisol given either to the mother prior to delivery or to the infant directly augmented the infant's hyperglycemic response to 30 µg/kg of glucagon. Some implications of these findings are discussed.

Sign in / Sign up

Export Citation Format

Share Document